84 related articles for article (PubMed ID: 641346)
1. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
Bartlett PF; Fenderson BA; Edidin M
J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
[TBL] [Abstract][Full Text] [Related]
2. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
Gooding LR
J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
4. Multiple splenic lymphoid cell subpopulations regulate H-2 antigen expression on teratocarcinoma cells in vivo.
Ostrand-Rosenberg S; Cohn AL; Sandoz JW
J Immunol; 1983 Jun; 130(6):2969-73. PubMed ID: 6133895
[TBL] [Abstract][Full Text] [Related]
5. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
Shain B; Holt CA; Lilly F
J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
9. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
Teh HS; Yu M
J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
[TBL] [Abstract][Full Text] [Related]
10. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells.
Subauste CS; Koniaris AH; Remington JS
J Immunol; 1991 Dec; 147(11):3955-9. PubMed ID: 1940378
[TBL] [Abstract][Full Text] [Related]
11. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
13. H-2 negative teratocarcinoma cells become H-2 positive when passaged in genetically resistant host mice.
Ostrand-Rosenberg S; Cohan VL
J Immunol; 1981 Jun; 126(6):2190-3. PubMed ID: 7229370
[TBL] [Abstract][Full Text] [Related]
14. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-activated lymphocytes from mice bearing a spontaneous "nonimmunogenic" adenocarcinoma inhibit its growth in vivo by recruiting host immunoreactivity.
Giovarelli M; Santoni A; Forni G
J Immunol; 1985 Nov; 135(5):3596-603. PubMed ID: 3930610
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
17. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
18. Induction and properties of cytotoxic T cells specific for hapten-coupled tumor cells.
Dennert G; Hatlen LE
J Immunol; 1975 Jun; 114(6):1705-12. PubMed ID: 805174
[TBL] [Abstract][Full Text] [Related]
19. Lysis of fresh natural killer-resistant tumor cells by lectin-activated syngeneic and allogeneic murine splenocytes.
Mazumder A; Rosenstein M; Rosenberg SA
Cancer Res; 1983 Dec; 43(12 Pt 1):5729-34. PubMed ID: 6640524
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
Paul RD; Padmanabhan R; Lopez DM
Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]